Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- People who have had their first-ever suspected or confirmed ischemic stroke (a stroke caused by a blocked blood vessel), identified through a physical examination and/or brain scan
- People whose stroke symptoms began less than 72 hours before being enrolled in the trial
- People who have been admitted to the stroke unit at CHU Brugmann or UZ Brussel hospitals
- People who are able to take part in assessments about fatigue, thinking and memory, mood, and sleep
- People who are able to have an MRI brain scan
Who may not be able to join:
- People who are not able to speak French or Dutch
- People who have had a previous stroke or who have another existing structural problem with the brain
- People with a life expectancy of less than one year
- People with severe difficulty understanding or using language, or with dementia, that would prevent them from completing the study assessments
- People who are pregnant or who are planning to become pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Anissa Ourtani, MD, CHU Brugmann
Phone: 3224754819
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Heart rate variability (HRV); Heart rate variability (HRV); Heart rate variability (HRV); Transthoracic echography (TTE); Transthoracic echography (TTE); Transthoracic echography (TTE); Fatigue Severity Scale (FSS-7); Fatigue Severity Scale (FSS-7); N-terminal pro-brain natriuretic peptide (NT-proBNP); N-terminal pro-brain natriuretic peptide (NT-proBNP); N-terminal pro-brain natriuretic peptide (NT-proBNP); cardiac troponin (cTnT); Non-Invasive Blood Pressure (NIBP); Non-Invasive Blood Pressure (NIBP); Non-Invasive Blood Pressure (NIBP); Baroreflex Sensitivity (BRS); Baroreflex Sensitivity (B...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.